Résumé
L’objectif de l’étude consistait à contrôler les résultats du Swedish adjustable gastric band (SAGB, anneau gastrique ajustable suédois) sur la base de l’intention de traiter dans plusieurs centres au sein du système français de sécurité sociale. Les résultats de suivi à 3 ans avec le SAGB sont présentés. Le plan de cette étude de cohorte non comparative, observationnelle, prospective et consécutive a visé le recrutement d’un minimum de 500 patients géographiquement représentatifs du territoire français métropolitain. L’innocuité (événements indésirables [EI], morbidité liée au dispositif, et mortalité) et l’efficacité (variation de l’indice de masse corporelle [IMC, kilogrammes par mètre carré], perte de poids en excès en pourcentage, comorbidités, qualité de vie [QoL]) ont été évaluées. La survie avec anneau gastrique ajustable a été calculée. Trente-et-un chirurgiens de 28 équipes / sites multidisciplinaires ont recruté des patients entre le 2 septembre 2007 et le 30 avril 2008. Un SAGB a été implanté avec succès chez 517 patients : 88,0 % de femmes ; âge moyen, 37,5 ans ; durée d’obésité, 15,3 ans (valeurs à l’inclusion : IMC moyen, 41,0 ; comorbidités, 773 chez 74,3 % des patients ; système d’analyse bariatrique et de notification des résultats (Bariatric Analysis and Reporting Outcome System, BAROS), 1,4 ; EuroQoL 5-Dimensions (EQ-5D), 0,61 ; échelle visuelle analogique EuroQoL (EQ-EVA), 52,3). À 3 ans : IMC, 32,2 (variation moyenne, −9,0 ; p < 0,0001) ; perte de poids en excès, 47,4 %; comorbidités, 161 chez 27,2 % ; BAROS, 3,6 (+2,2, p < 0,0001) ; EQ-5D, 0,84 (+0,22, p < 0,0001) ; EQ-EVA, 73,4 (+21,4, p < 0,0001). La perte de poids induite par le SAGB était associée à une amélioration substantielle de la QoL. Un décès est survenu, sans rapport avec le traitement. 68,3 % des patients n’ont rapporté aucun EI, et 77,0 % aucun EI confirmé et lié au dispositif. Le taux global d’EI était de 0,19 par patients-année. La conservation du dispositif était de 87,0 %. L’analyse des patients perdus de vue a montré un effet non significatif sur les résultats globaux de l’étude. Le Swedish Adjustable Gastric Band est apparu sûr et efficace dans le suivi à 3 ans d’une étude nationale de cohorte consécutive, prospective et dans la population générale.
Abstract
The study objective was to ascertain outcomes with the Swedish adjustable gastric band (SAGB) on an intention-to-treat basis in multiple centers across the French social health insurance system. SAGB results at 3-year follow-up are reported. The noncomparative, observational, prospective, consecutive cohort study design sought a 500 patient minimum recruitment geographically representative of continental France. Safety (adverse events [AEs], devicerelated morbidity, and mortality) and effectiveness (change in body mass index [BMI, kilograms per square meter], percentage excess weight loss, comorbidities, quality of life [QoL]) were assessed. Adjustable gastric band survival was calculated. Thirty-one surgeons in 28 multidisciplinary teams/ sites enrolled patients between September 2, 2007 and April 30, 2008. SAGB was successfully implanted in 517 patients: 88.0 % female; mean age, 37.5 years; obesity duration, 15.3 years (baseline: mean BMI, 41.0; comorbidities, 773 in 74.3%of patients; Bariatric Analysis and Reporting Outcome System (BAROS), 1.4; EuroQoL 5-Dimensions (EQ-5D), 0.61; EuroQoL-visual analog scale (EQ-VAS), 52.3). At 3 years: BMI, 32.2 (mean change, −9.0; p<0.0001); excess weight loss, 47.4 %; comorbidities, 161 in 27.2 %; BAROS, 3.6 (+2.2, p<0.0001); EQ-5D, 0.84 (+0.22, p<0.0001); EQ-VAS, 73.4 (+21.4, p<0.0001). SAGB-induced weight loss was associated with substantially improved QoL. One death occurred and was unrelated to the treatment. No AE was reported in 68.3 % of patients, and no confirmed devicerelated AE in 77.0 %. Overall AE rate was 0.19 per patient year. Device retention was 87.0 %. Analysis of patients lost to follow-up showed a nonsignificant effect on overall study results. In a prospective, consecutive cohort, “real-world”, nationwide study, the Swedish Adjustable Gastric Band was found safe and effective at 3-year follow-up.
Références
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19:1605–1611.
Basdevant A, Paita M, Rodde-Dunet M-H, et al A nationwide survey on bariatric surgery: two years prospective follow-up. Obes Surg. 2007;17:39–44.
Avis de la CEPP du 1er septembre 2004 modifié le 20 octobre 2004 SAGB (anneau gastrique ajustable suédois), implant annulaire ajustable pour gastroplastie. Modèles 2100-X et 2200-X. http://www.santedev.org/biblio/pdf2/has/cepp/2004/10/20/pp020367.pdf. Consulté le 12 mars 2012
Avis de la CEPP 8 mars 2006 SAGB (anneau gastrique ajustable suédois) Quick-Close fourni avec le site VELOCITY et son applicateur, implant annulaire ajustable pour gastroplastie. Modèle BD2XV.
Association Française d’Etudes et de Recherches sur l’Obésité, Association de Langue Française pour l’Etude du Diabète et des Maladies Métaboliques, Société de Nutrition et de Diététique de Langue Française. Recommandations pour le diagnostic, la prévention et le traitement des obésités en France. Cah Nutr Diet. 1998;33:10–42.
Haute Autorité de Santé: Obésité: prise en charge chirurgicale chez l’adulte. Recommandations de bonnes pratiques professionnelles. January 2009. http://www.has-sante.fr/portail/jcms/c_765529/obesite-prise-en-charge-chirurgicale-chez-l-adulte. Consulté le 12 mars 2012
Prospective National Cohort Study on Swedish Adjustable Gastric Band (SAGB) for Gastroplasty (Étude de Cohorte Nationale Pro-spective de l’Implant Annulaire Ajustable Pour Gastroplastie SAGB). PROTOCOL No: 05-FR-004 1.0. Protocole disponible à l’adresse: clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01183975?term0ethicon+endo-surgery&rank015
Clinical investigation of medical devices for human subjects — part 1: general requirements. (Investigation clinique des dispositifs médicaux pour sujets humains — Partie 1: Exigences générales) International Standard Ref. ISO 14155-1:2003(E).
Clinical investigation of medical devices for human subjects — part 1: clinical investigation plans. (Investigation clinique des dispositifs médicaux pour sujets humains — Partie 2: Plans d’investigation clinique) International Standard Ref. ISO 14155-2:2003 (E). Première édition 15 mai 2003.
World Medical Association. 7 Declaration of Helsinki: ethical principles for medical research involving human subjects, 22 octobre 2008. www.wma.net/en/30publications/10policies/b3/index.html.
NIH. Gastrointestinal surgery for severe obesity. NIH Consensus Statement 1991; Mar 25–27;9(1):1–20.
Fried M, Hainer V, Basdevant A, et al Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31(4):569–577.
WHO: Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Genèva: Organisation Mondiale de la Santé, 1995.
Lorentz FH. Ein neuer Konstitionsinde. Klin Wochenschr. 1929;8:348–351.
Lorentz FH. Ein neuer Konstitionsinde der Frau. Klin Wochenschr. 1929;16:734–736.
Miller MA. A calculated method for the determination of ideal body weight. Nutr Support Serv. 1985;5(3):31–33.
Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13(2):159–160.
Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998;9:947–954.
Nini E, Slim K, Scesa JL, et al Evaluation de la chirurgie coelioscopique de l’obésité par le score BAROS. Ann Chir. 2002;127(2):107–114.
Ackroyd R, Mouiel J, Chevallier JM, et al Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in 3 European countries. Obes Surg. 2006;16:1488–1503.
EuroQoL Group. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16: 199–208.
Dolan P, Gudex C, Kind P, et al A social tariff for EuroQoL: results from a UK general population survey, in York Centre for Health Economics Discussion Paper. University of York: York, UK; 1990.
Kind P, Dolan P, Gudex C, et al Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736–741.
Dixon S, Farina C, McEwan P, et al Evaluation of the association between health-related utility and obesity in hospital treated subjects. Value Health. 2004;7:331.
Brazier J, Roberts J, Tsuchiya A, et al A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13: 873–874.
Di Lorenzo N, Furbetta F, Favretti F, et al Laparoscopic gastric banding via pars flaccida versus perigastric positioning: technique, complications, and results in 2,549 patients. Surg Endosc. 2010;24:1519–1523.
Nguyen NT, Slone JA, Nguyen XM, et al A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250(4):631–641.
Himpens J, Cadière GB, Bazi M, et al Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg. 2011;146(7):802–807.
Buchwald H, Estok R, Fahrbach K, et al Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–632. discussion 632–5.
Champault A, Duwat O, Polliand C, et al Quality of life after laparoscopic gastric banding: prospective study (152 cases) with a follow-up of 2 years. Surg Laparosc Endosc Percutan Tech. 2006;16(3):131–136.
Sach TH. The relationship between BMI and HR-QoL: comparing the EQ-5D, EuroQol VAS and SF-6D. Int J Obes. 2007;31:189–196.
National Library of Medicine. Electronic PubMed database search for adjustable gastric banding. http://www.ncbi.nlm.nih.gov/pubmed?term0adjustable%20gastric%20banding. Consulté le 20 mars 2012.
Apovian CM, Cummings S, Anderson W, et al Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring). 2009;17(5):871–879. Epub 2009 19 fév.
American Society for Metabolic and Bariatric Surgery (ASMBS). http://asmbs.org/2012/03/unified-national-accreditation-programfor-bariatric-surgery-centers-announced-by-american-college-ofsurgeons-and-american-society-for-metabolic-and-bariatric-surgery/. Consulté le 20 mars 2012
American College of Surgeons National Surgical Quality Improvement Program (NSQIP). http://site.acsnsqip.org/about/business-case/. Consulté le 15 mars 2012
Surgical Review Corporation (SRC). http://www.surgicalreview.org/coeprograms/bariatric/. Consulté le 15 mars 2012
Rubin M, Spivak H. Prospective study of 250 patients undergoing laparoscopic gastric banding using the two-step technique: a technique to prevent postoperative slippage. Surg Endosc. 2003;17(6):857–860.
Naef M, Naef U, Mouton WG, et al Outcome and complications after laparoscopic Swedish adjustable gastric banding: 5-year results of a prospective clinical trial. Obes Surg. 2007;17(2):195–201.
Steffen R, Biertho L, Ricklin T, et al Laparoscopic Swedish adjustable gastric banding: a five-year prospective study. Obes Surg. 2003;13(3):404–411.
Fielding GA. Laparoscopic adjustable gastric banding for massive superobesity (>60 body mass index kg/m2). Surg Endosc. 2003;17(10):1541–1545.
Fox SR, Fox KM, Srikanth MS, et al The Lap-Band system in a North American population. Obes Surg. 2003;13(2):275–280.
Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg. 2005;201(4):529–535.
Jan JC, Hong D, Pereira N, et al Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results. J Gastrointest Surg. 2005;9(1):30–41.
Buchwald H, Estok R, Fahrbach K, et al Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–632. discussion 632–635.
Garb J, Welch G, Zagarins S, et al Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg. 2009;19(10):1447–1455.
Nguyen NT, Hohmann S, Slone J, et al Improved bariatric surgery outcomes for Medicare beneficiaries after implementation of the medicare national coverage determination. Arch Surg. 2010;145(1):72–78.
Sánchez-Santos R, Masdevall C, Baltasar A, et al Short- and midterm outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009;19(9):1203–1210. Epub 2009 Jul 2.
Sundbom M, Karlson BM. Low mortality in bariatric surgery 1995 through 2005 in Sweden, in spite of a shift to more complex procedures. Obes Surg. 2009;19(12):1697–1701.
Schilling PL, Davis MM, Albanese CT, et al National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg. 2008;206(1):1–12. Epub 2007 Oct 18.
Morino M, Toppino M, Forestieri P, et al Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg. 2007;246(6):1002–1007. discussion 1007–9.
Ricciardi R, Town RJ, Kellogg TA, et al Outcomes after open versus laparoscopic gastric bypass. Surg Laparosc Endosc Percutan Tech. 2006;16(5):317–320.
Davis MM, Slish K, Chao C, et al National trends in bariatric surgery, 1996-2002. Arch Surg. 2006;141(1):71–74. discussion 7
Carbonelli AM, Lincourt AE, Matthews BD, et al National study of the effect of patient and hospital characteristics on bariatric surgery outcomes. Am Surg. 2005;71(4):308–314.
Nguyen NT, Root J, Zainabadi K, et al Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg. 2005;140(12):1198–1202. discussion 1203.
Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909–1917.
Trus TL, Pope GD, Finlayson SR. National trends in utilization and outcomes of bariatric surgery. Surg Endosc. 2005;19(5): 616–620. Epub 2005 Mar 11.
Poulose BK, Holzman MD, Zhu Y, et al National variations in morbid obesity and bariatric surgery use. J Am Coll Surg. 2005;201(1):77–84.
Angrisani L, Di Lorenzo N, Favretti F, et al The Italian Group for LAP-BAND: predictive value of initial body mass index for weight loss after 5 years of follow-up. Surg Endosc. 2004;18(10):1524–1527. Epub 2004 Aug 26.
Belle SH, Berk PD, Courcoulas AP, et al Longitudinal Assessment of Bariatric Surgery Consortium Writing Group. Safety and efficacy of bariatric surgery: longitudinal assessment of bariatric surgery. Surg Obes Relat Dis. 2007;3(2):116–126.
Kakarla VR, Nandipati K, Lalla M, et al Are laparoscopic bariatric procedures safe in superobese (BMI ≥50 kg/m2) patients? A NSQIP data analysis. Surg Obes Relat Dis. 2011;7(4):452–458.
Demaria EJ, Winegar DA, Pate VW, et al Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252(3):559–566. discussion 566–7.
World Health Organization: WHO Global Infobase: country collected data, 2010. Consultable à l’adresse: https://apps.who.int/infobase/comparestart.aspx.
Burns EM, Naseem H, Bottle A, et al Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ. 2010;341:c4296.
Harbottle L. Audit of nutritional and dietary outcomes of bariatric surgery patients. Obes Rev. 2011;12(3):198–204.
Schauer DP, Arterburn DE, Livingston EH, et al Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg. 2010;145(1):57–62.
Martin M, Beekley A, Kjorstad R, et al Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1): 8–15. Epub 2009 17 Juil.
Stroh C, Birk D, Flade-Kuthe R, et al A nationwide survey on bariatric surgery in Germany—results 2005-2007. Obes Surg. 2009;19(1):105–112. Epub 2008 Oct 2
Santos LM, de Oliveira IV, Peters LR, et al Trends in morbid obesity and in bariatric surgeries covered by the Brazilian Public Health System. Obes Surg. 2010;20(7):943–948. Epub 2008 7 Juin.
Christou NV, Efthimiou E. Bariatric surgery waiting times in Canada. Can J Surg. 2009;52(3):229–234.
Dallal RM, Datta T, Braitman LE. Medicare and Medicaid status predicts prolonged length of stay after bariatric surgery. Surg Obes Relat Dis. 2007;3(6):592–596. Epub 2007 23 Oct.
Chevallier J-M, Paita M, Rodde-Dunet M-H. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients’ behavior. Ann Surg. 2007;246(6):1034–1039.
Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med. 2007;161(3):217–221.
Santry HP, Chin MH, Cagney KA, et al The use of multidisciplinary teams to evaluate bariatric surgery patients: results from a national survey in the USA. Obes Surg. 2006;16(1):59–66.
Sjostrom L, Lindroos A-K, Peltonen M, et al Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM. 2004;351(26):2683–2693.
Phillips E, Ponce J, Cunneen SA. Safety and effectiveness of REALIZE adjustable gastric band: 3-year prospective study in the United States. Surg Obes Rel Dis. 2009;5:588–597.
Gouillat C, Denis A, Badol-Van Straaten P, et al Prospective, multicenter, 3-year trial of laparoscopic adjustable gastric banding with the MIDBANDTM. Obes Surg. 2012;22(4):572–581.
Chapman AE, Kiroff G, Game P, et al Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery. 2004;135:326–351.
Tice JA, Karliner L, Walsh J, et al Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885–893.
O’Brien PE, McPhail T, Chaston TB, et al Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–1040.
Cunneen SA, Phillips E, Fielding G, et al Studies of Swedish adjustable gastric band and Lap-Band: systematic review and meta-analysis. Surg Obes Relat Dis. 2008;4(2):174–185. Epub 2008 Feb 1. Review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribaric, G., Buchwald, J.N., d’Orsay, G. et al. Résultats à 3 ans du Swedish Adjustable Gastric BandTM (anneau gastrique ajustable suédois) dans la population générale en France. Obes 8, 8–21 (2013). https://doi.org/10.1007/s11690-013-0356-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-013-0356-y
Mots clés
- Anneau gastrique ajustable par laparoscopie
- Obésité
- Résultats nationaux
- Swedish adjustable gastric band
- SAGB
- Qualité de vie
- BAROS
- EQ-5D
- QALY